Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Lanzafame

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 23, 2024
Prognostic Implications of <sup>68</sup>Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid TumorsMasao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Life (Basel, Switzerland)|September 28, 2023
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the LiteraturePriscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, et al.
Annals of Nuclear Medicine|October 23, 2024
Head-to-head comparison of <sup>68</sup> Ga-FAPI-46 PET/CT, <sup>18</sup>F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumorsMasao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Diagnostic Accuracy of <sup>68</sup>Ga-FAPI Versus <sup>18</sup>F-FDG PET in Patients with Various MalignanciesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After ProstatectomyConstantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2023
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective studySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 23, 2024
Prognostic Implications of <sup>68</sup>Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid TumorsMasao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Life (Basel, Switzerland)|September 28, 2023
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the LiteraturePriscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, et al.
Annals of Nuclear Medicine|October 23, 2024
Head-to-head comparison of <sup>68</sup> Ga-FAPI-46 PET/CT, <sup>18</sup>F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumorsMasao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Diagnostic Accuracy of <sup>68</sup>Ga-FAPI Versus <sup>18</sup>F-FDG PET in Patients with Various MalignanciesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After ProstatectomyConstantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2023
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective studySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Pageof 2